 | |
| |
| |
| |
 | |
| |
|
|
|
|
| | |
|||
|
|
|
Topics
Consumer Concerns and Advice Recent UpdatesMay 12, 2008 May 05, 2008 April 30, 2008 April 22, 2008 April 14, 2008 Archives
May, 2008 Web ResourcesChalat Hatten Law Offices
|
When you think of the legal issues arising from health care, the obvious association is medical malpractice by a doctor. Yet, as our modern health care system has become increasingly complex so to has the range of malpractice occurrences. And malpractice is not the only legal concern - your legal rights are often defined by medical insurance coverage and subrogation, HIPPA requirements, state and federal benefits, living wills and quality of life issues. For those with a legal question arising from medical care, the postings under this topic provide some answers.
FDA Conflicts To Be Limited The Food and Drug Administration took a step many consider long-overdue and proposed new rules yesterday that would make it tougher for scientists with industry ties to offer advice about approving new drugs and medical devices. The FDA said that most scientists with $50,000 or more in stock, consulting fees or other financial links to companies should be barred from making recommendations to the agency about a related product. Scientists with smaller financial interests would be allowed to participate in agency advisory meetings but could not vote.
Home Sweet Home It's Not Earlier this week The Boston Globe reported on the very sad case of 77-year-old Jean Dwyer. Mrs. Dwyer seemed distressed as she lay in her bed at a Norwell, MA nursing home last fall, but she could not explain to her grown daughter what was wrong due to the mother's dementia. Her daughter attended her bedside daily for a couple of weeks, and was ultimately told that her mother's organs were shutting down and that she was near death.
Cadaver Parts Becoming "Growth Industry"? Last Halloween it was New York City funeral homes partaking in clandestine selling of cadaver parts, see Modern Day Body Snatchers - now the former director of the cadaver donor program at the University of California, Los Angeles, along with his modern-day Igor, have been charged with conspiracy and grand theft. Both have been accused of illegally trading body parts that had been donated to the University for Medical Research.
Fair Trials for New Drugs? We hear daily reports on results from clinical trials for new drugs, and they have a tendency to show positive results - particularly in trials with drug-company funding. A new study appearing on the website of the American Cancer Society, analyzes 140 trials of breast-cancer drugs. In 2003, trials with pharmaceutical-company backing showed positive results in 84% of the studies, compared to just 54 % for trials without industry backing. |
|
The information you obtain at this site is not, nor is it intended to be, legal advice. You should consult an attorney for individual advice regarding your own situation. | |
